Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66).
Yokoyama H, Araki SI, Yamazaki K, Kawai K, Shirabe SI, Oishi M, Kanatsuka A, Yagi N, Kabata D, Shintani A, Maegawa H; JDDM study group. Yokoyama H, et al. Among authors: araki si. BMJ Open Diabetes Res Care. 2022 May;10(3):e002727. doi: 10.1136/bmjdrc-2021-002727. BMJ Open Diabetes Res Care. 2022. PMID: 35504696 Free PMC article.
Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40).
Yokoyama H, Oishi M, Takamura H, Yamasaki K, Shirabe SI, Uchida D, Sugimoto H, Kurihara Y, Araki SI, Maegawa H. Yokoyama H, et al. Among authors: araki si. BMJ Open Diabetes Res Care. 2016 Oct 3;4(1):e000294. doi: 10.1136/bmjdrc-2016-000294. eCollection 2016. BMJ Open Diabetes Res Care. 2016. PMID: 27752329 Free PMC article.
Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46).
Yokoyama H, Araki SI, Kawai K, Yamazaki K, Tomonaga O, Shirabe SI, Maegawa H. Yokoyama H, et al. Among authors: araki si. BMJ Open Diabetes Res Care. 2018 May 29;6(1):e000521. doi: 10.1136/bmjdrc-2018-000521. eCollection 2018. BMJ Open Diabetes Res Care. 2018. PMID: 29892340 Free PMC article.
The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
Yokoyama H, Araki SI, Kawai K, Yamazaki K, Shirabe SI, Sugimoto H, Minami M, Miyazawa I, Maegawa H; JDDM Study Group. Yokoyama H, et al. Among authors: araki si. Diabetes Care. 2020 May;43(5):1102-1110. doi: 10.2337/dc19-2049. Epub 2020 Mar 6. Diabetes Care. 2020. PMID: 32144168
Applications of physical performance measures to routine diabetes care for frailty prevention concept: fundamental data with grip strength, gait speed, timed chair stand speed, standing balance, and knee extension strength.
Yokoyama H, Shiraiwa T, Takahara M, Iwamoto M, Kuribayashi N, Nomura T, Yamada M, Sone H, Araki SI. Yokoyama H, et al. Among authors: araki si. BMJ Open Diabetes Res Care. 2020 Sep;8(1):e001562. doi: 10.1136/bmjdrc-2020-001562. BMJ Open Diabetes Res Care. 2020. PMID: 32948539 Free PMC article.
Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36).
Yokoyama H, Araki S, Kawai K, Hirao K, Oishi M, Sugimoto K, Sone H, Maegawa H, Kashiwagi A; Japan Diabetes Clinical Data Management Study Group. Yokoyama H, et al. Diabetes Res Clin Pract. 2015 Sep;109(3):485-92. doi: 10.1016/j.diabres.2015.06.005. Epub 2015 Jul 16. Diabetes Res Clin Pract. 2015. PMID: 26261056
225 results